Search research articles
Contact Us
Filters
Showing results (41-50 of 61) with videos related to
Page
of 7
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging
|
November 12, 2024
EANM expert opinion: How can lessons from radiobiology be applied to the design of clinical trials? Part I: back to the basics of absorbed dose-response and threshold absorbed doses
Jean-Pierre Pouget, Pablo Minguez Gabina, Ken Herrmann, et al.
Clinical Nutrition (Edinburgh, Scotland)
|
September 14, 2018
Artificial nutrition in patients with cancer has no impact on tumour glucose metabolism: Results of the PETANC Study
Emmanuel Deshayes, Hélène de Forges, Julien Fraisse, et al.
Medical Physics
|
July 8, 2020
Comparison of commercial dosimetric software platforms in patients treated with <sup>177</sup> Lu-DOTATATE for peptide receptor radionuclide therapy
Erick Mora-Ramirez, Lore Santoro, Emmanuelle Cassol, et al.
Breast Cancer Research : BCR
|
February 8, 2011
Vaccination with human anti-trastuzumab anti-idiotype scFv reverses HER2 immunological tolerance and induces tumor immunity in MMTV.f.huHER2(Fo5) mice
Maha Z Ladjemi, Thierry Chardes, Stephanie Corgnac, et al.
Plos One
|
August 8, 2013
Comparison between internalizing anti-HER2 mAbs and non-internalizing anti-CEA mAbs in alpha-radioimmunotherapy of small volume peritoneal carcinomatosis using 212Pb
Vincent Boudousq, Laure Bobyk, Muriel Busson, et al.
Pharmacology & Therapeutics
|
October 23, 2021
Therapeutic antibodies - natural and pathological barriers and strategies to overcome them
Yara Al Ojaimi, Timothée Blin, Juliette Lamamy, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 27, 2025
MHC-I-Driven Antitumor Immunity Counterbalances Low Absorbed Doses of Radiopharmaceutical Therapy
Julie Constanzo, Aliasghar Parach, Timothee David, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 20, 2010
Brief intraperitoneal radioimmunotherapy of small peritoneal carcinomatosis using high activities of noninternalizing 125I-labeled monoclonal antibodies
Vincent Boudousq, Stéphanie Ricaud, Véronique Garambois, et al.
Antioxidants & Redox Signaling
|
May 26, 2016
Localized Irradiation of Cell Membrane by Auger Electrons Is Cytotoxic Through Oxidative Stress-Mediated Nontargeted Effects
Salomé Paillas, Riad Ladjohounlou, Catherine Lozza, et al.
Mabs
|
December 18, 2014
The human Müllerian inhibiting substance type II receptor as immunotherapy target for ovarian cancer. Validation using the mAb 12G4
Nathalie Kersual, Véronique Garambois, Thierry Chardès, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 61) with videos related to
Sort By:
Page
of 7
European Journal of Nuclear Medicine and Molecular Imaging
|
November 12, 2024
EANM expert opinion: How can lessons from radiobiology be applied to the design of clinical trials? Part I: back to the basics of absorbed dose-response and threshold absorbed doses
Jean-Pierre Pouget, Pablo Minguez Gabina, Ken Herrmann, et al.
Clinical Nutrition (Edinburgh, Scotland)
|
September 14, 2018
Artificial nutrition in patients with cancer has no impact on tumour glucose metabolism: Results of the PETANC Study
Emmanuel Deshayes, Hélène de Forges, Julien Fraisse, et al.
Medical Physics
|
July 8, 2020
Comparison of commercial dosimetric software platforms in patients treated with <sup>177</sup> Lu-DOTATATE for peptide receptor radionuclide therapy
Erick Mora-Ramirez, Lore Santoro, Emmanuelle Cassol, et al.
Breast Cancer Research : BCR
|
February 8, 2011
Vaccination with human anti-trastuzumab anti-idiotype scFv reverses HER2 immunological tolerance and induces tumor immunity in MMTV.f.huHER2(Fo5) mice
Maha Z Ladjemi, Thierry Chardes, Stephanie Corgnac, et al.
Plos One
|
August 8, 2013
Comparison between internalizing anti-HER2 mAbs and non-internalizing anti-CEA mAbs in alpha-radioimmunotherapy of small volume peritoneal carcinomatosis using 212Pb
Vincent Boudousq, Laure Bobyk, Muriel Busson, et al.
Pharmacology & Therapeutics
|
October 23, 2021
Therapeutic antibodies - natural and pathological barriers and strategies to overcome them
Yara Al Ojaimi, Timothée Blin, Juliette Lamamy, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 27, 2025
MHC-I-Driven Antitumor Immunity Counterbalances Low Absorbed Doses of Radiopharmaceutical Therapy
Julie Constanzo, Aliasghar Parach, Timothee David, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 20, 2010
Brief intraperitoneal radioimmunotherapy of small peritoneal carcinomatosis using high activities of noninternalizing 125I-labeled monoclonal antibodies
Vincent Boudousq, Stéphanie Ricaud, Véronique Garambois, et al.
Antioxidants & Redox Signaling
|
May 26, 2016
Localized Irradiation of Cell Membrane by Auger Electrons Is Cytotoxic Through Oxidative Stress-Mediated Nontargeted Effects
Salomé Paillas, Riad Ladjohounlou, Catherine Lozza, et al.
Mabs
|
December 18, 2014
The human Müllerian inhibiting substance type II receptor as immunotherapy target for ovarian cancer. Validation using the mAb 12G4
Nathalie Kersual, Véronique Garambois, Thierry Chardès, et al.
Page
of 7